Association of Coffee With Periodontal Status (acpc)

November 18, 2025 updated by: Tuğba ŞAHİN

Association of Coffee Consumption With Periodontal Health and Disease: An Observational Study

A total of 318 patients applying to Bolu Abant İzzet Baysal University will be included in the study. Based on anamnesis, radiographic examination, and the 2018 classification of periodontal diseases, the participants will be categorized into three groups: periodontal health (n=106), gingivitis (n=106), and periodontitis (n=106). Information regarding participants' coffee consumption habits and their daily coffee intake will be collected. Clinical parameters to be measured will include plaque index, gingival index, bleeding on probing, gingival recession, and clinical attachment level.

The frequency of coffee consumption will be evaluated as daily, 1-2 times per week, 3-4 times per week, once per month, twice per month, and once per year. The amount of coffee consumed at a single occasion (cup, glass, mug, etc.) will also be recorded. In caffeinated coffee consumption, the preference for weak, moderate, or strong coffee, as well as consumption with milk, condensed milk, sugar, honey, or sweeteners will be assessed. For Turkish coffee, the consumption pattern will be categorized as unsweetened, moderately sweetened, or sweetened.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

318

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bolu, Turkey (Türkiye), 14030
        • Bolu abant Izzet Baysal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Individuals with periodontitis, gingivitis, and periodontal disease

Description

Inclusion Criteria:

  • Healthy individuals were between 18 and 65 years

Exclusion Criteria:

  • Individuals were excluded if they had smoked more than 100 cigarettes in their lifetime, were current smokers, had a diagnosis of uncontrolled diabetes mellitus, were pregnant, or were breastfeeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Periodontitis
It refers to a chronic inflammatory disease of the supporting tissues of the teeth, characterized by progressive destruction of the periodontal ligament and alveolar bone, with pocket formation and/or gingival recession.
The type of coffee consumed, the daily amount of coffee, and the frequency of consumption were measured.
Gingivitis
It refers to a reversible inflammation of the gingival tissues without loss of periodontal attachment. The condition is primarily induced by dental plaque accumulation and is characterized clinically by signs such as gingival redness, swelling, and bleeding on probing.
The type of coffee consumed, the daily amount of coffee, and the frequency of consumption were measured.
Periodontal health
Periodontal health refers to the absence of clinical signs of inflammation in the periodontium, with stable supporting tissues and no evidence of attachment loss or bone destruction.
The type of coffee consumed, the daily amount of coffee, and the frequency of consumption were measured.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bleeding on probing
Time Frame: baseline
To test for bleeding after probing, the probe is carefully introduced to the bottom of the pocket and gently moved laterally along the pocket wall. + is maximum and - is minimum.
baseline
Frequency of consumption of fermented foods
Time Frame: baseline
the frequency of fermented foods is measured. The foods questioned were evaluated using a 7-point Likert-type frequency form (every day, 3-4 per week, 1-2 per week, 2 per month, 1 per month, never). In addition, the amounts of foods consumed each time were recorded, and the daily consumption amounts were obtained by dividing them by the frequency of consumption.
baseline
periodontal pocket depth
Time Frame: Baseline
physical methods to measure the distance from the bottom of a pocket to a reference line, usually the gingival margin or the cemento-enamel junction.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
clinical attachment level
Time Frame: baseline
The clinical attachment level (CAL) and radiographically assessed bone levels are used to assess the loss of periodontal tissue support in periodontitis, a chronic, multifactorial inflammatory disease of the periodontium.
baseline
plaque index
Time Frame: baseline
an index for estimating the status of oral hygiene by measuring dental plaque that occurs in the areas adjacent to the gingival margin. 0 is minimum and 3 is maximum. The situation worsens as the score increases.
baseline
gingival index
Time Frame: baseline
The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding. 0 is minimum and 3 is maximum. The situation worsens as the score increases.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 19, 2024

Primary Completion (Actual)

July 28, 2025

Study Completion (Actual)

August 28, 2025

Study Registration Dates

First Submitted

September 3, 2025

First Submitted That Met QC Criteria

September 3, 2025

First Posted (Estimated)

September 10, 2025

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on coffee

Subscribe